PAZONAT (Pazopanib) is a tyrosine kinase inhibitor that blocks vascular endothelial growth factor receptors, reducing blood supply to tumours and inhibiting their growth.
Recommended for:
PAZONAT should be taken orally, one hour before or two hours after meals, as directed by a physician. Duration and dosage depend on individual response and clinical guidelines.
Contraindications:
Side Effects: